Report Publication

This page displays our monthly publication covering upcoming Phase 3 clinical trial catalysts.

CatalyScope is an independent clinical industry publisher focused on primary endpoint readouts within small- and mid-cap pharmaceutical and biotechnology companies. The report compiles publicly available data into a structured, standardized format to support independent research into clinical development activity.

Each edition provides a consolidated snapshot of selected clinical programs, including:

• Executive overview of included trials
• Trial design details (status, interventions, enrollment, and timelines)
• Development context and historical phase transition benchmarks
• Company pipeline summaries
• Indication-specific market context, including estimated market size, growth outlook, and competitive landscape information

All information is derived from publicly available sources and presented in a consolidated research format. The purpose of the report is informational and educational only.